7 Billion Doses of COVID-19 Vaccine for World’s Population of 7 Billion – Was This the Plan All Along?

The COVID-19 pandemic has created an instant market for vaccine development. Around $1 billion of U.S. taxpayer funds have already been given to Big Pharma to develop the much coveted COVID-19 mRNA vaccine, a new class of vaccines that have never before been successfully developed. At least another $2 billion is being spent by the Bill Gates-founded Coalition for Epidemic Preparedness Innovations (CEPI). And this is all just for starters, as over 100 COVID-19 vaccines are currently in development by most of the world's largest pharmaceutical companies. The CARES Act signed into law on Mar. 27, 2020 allocates $27 billion for COVID-19 vaccine development, just in the U.S. alone. And if that wasn't enough, earlier this week (May, 2020) President Trump seemingly gave a blank check to spend as much as possible to fast track a COVID-19 vaccine through "Operation Warp Speed," a coalition of scientists, government officials, military agencies, and private companies led by Alex Azar, the Health and Human Services Secretary, and Mark Esper, the Defense Secretary. Their goal: to deliver 300 million doses of coronavirus vaccine from November to December 2020 and another 300 million by January 2021. So just by starting to research a COVID-19 vaccine, the already lucrative pharmaceutical industry just became the all-time most profitable industry on the planet. As pharmaceutical companies compete with each other to get a COVID-19 vaccine to market, there was initial skepticism that an mRNA vaccine could be developed anytime soon. Projections were that it would take about 5 years, and even then only with a small chance of success. Now, as we saw earlier this week with the announcement of the new "Operation Warp Speed" project, the projections are to produce enough vaccines to be able to inject all 350 million citizens of the United States by the end of 2020. And on May 1st this week Moderna Therapeutics announced a partnership with Lonza manufacturing to start producing 1 billion COVID-19 vaccines a year. Moderna Therapeutics is partnering with Dr. Anthony Fauci of the National Institutes of Health (NIH), who also has close ties to Bill Gates. Bill Gates said in an interview this week that 7 billion vaccine doses are needed to end the COVID-19 pandemic, which is about the same number as the number of people living on the planet. Will the entire world's population just volunteer to get this vaccine, or are the drug companies counting on the fact that they will become mandatory? The world's largest manufacturer of vaccines, the Serum Institute of India, which produces 1.5 billion vaccine doses a year for an array of diseases, said it was not going to wait for approval of a COVID-19 vaccine, but would start manufacturing them immediately, starting with 40 million doses. They are currently working with the the Oxford Vaccine Group. It would seem that pharmaceutical companies manufacturing a COVID-19 vaccine are banking on the fact that the World Health Organization will recommend that they be mandatory. Will the U.S. comply?

Dr. Fauci’s Attempt to Silence Whistleblower Dr. Judy Mikovits Which Destroyed her Career

Dr. Mikovits joined NIH in 1980 as a Postdoctoral Scholar in Molecular Virology at the National Cancer Institute and began a 20-year collaboration with Frank Ruscetti, a pioneer in the field of human retro virology. She helped Dr. Russetti isolate the HIV virus and link it to #AIDS in 1983. Her NIH boss Anthony Fauci delayed publication of that critical paper for 6 months to let his protégé Robert Gallo replicate, publish and claim credit. The delay in mass HIV testing let AIDS further spread around the globe and helped Fauci win promotion to director NIAID. In 2006, Dr. Mikovits became director of Whittemore Peterson Institute for Neuro-Immune Disease and collaborated with Dr. Ruscetti searching for the cause of Chronic Fatigue Syndrome which suddenly became an epidemic in the 1980s. The male-dominated medical community dismissed CFS as psychosomatic “yuppie flu” caused when fragile females cracked in corporate jobs. Dr. Mikovits discovered that 67% of affected women carried a virus—called Xenotropic Murine Leukemia related Virus—that appeared in healthy women only 4% of the time. XMRV is also associated with prostate, breast, ovarian cancers, leukemia, and multiple myeloma. Many women with XMRV bore children with autism. In 2009, Drs. Mikovits and Ruscetti published their explosive findings in the journal Science. But the question remained: how was XMRV getting into people? Other researchers linked the first CFS outbreak to a polio vaccine given to doctors and nurses that resulted in the “1934 Los Angeles County Hospital Epidemic.” That vaccine was cultivated on pulverized mouse brains. Retroviruses from dead animals can survive in cell lines and permanently contaminate vaccines. Dr. Mikovits’ studies suggested that the XMRV Virus was present in the MMR, Polio and Encephalitis vaccines given to American children and soldiers. XMRV is so hazardous that the mere presence of mouse tissue in a laboratory can contaminate other tissues in the same room. Dr. Fauci ordered Mikovits to keep her mouth shut. When she refused, he illegally confiscated her work books and hard drives, drove her from government work and blackballed her from receiving NIH grants ending her science career. XMRV remains in American vaccines.

Dr. Anthony Fauci’s NIAID Gave $3.7 Million to Scientists at the Chinese Wuhan Lab at Center of Coronavirus Outbreak

The Daily Mail reported that it has uncovered documents showing that Dr. Anthony Fauci’s National Institute of Allergy and Infectious Disease (NIAID) gave $3.7 million to scientists at the Wuhan Lab at the center of coronavirus leak scrutiny. According to the British paper, “the federal grant funded experiments on bats from the caves where the virus is believed to have originated.” Following the 2002-2003 SARS coronavirus outbreak, NIH funded a collaboration by Chinese scientists, US military virologists from the bioweapons lab at Fort Detrick and National Institutes of Health (NIH) scientists from NIAID to prevent future coronavirus outbreaks by studying the evolution of virulent strains from bats in human tissues. Those efforts included “gain of function” research which is “accelerated viral evolution” to create COVID Pandemic superbugs, enhanced bat borne COVID mutants more lethal and more transmissible than wild COVID. Fauci’s studies alarmed scientists around the globe who complained, according to a December 2017 NY Times article, that “these researchers risk creating a monster germ that could escape the lab and seed a pandemic.” Dr. Marc Lipsitch of the Harvard School of Public Health’s Communicable Disease Center told the Times that Dr. Fauci’s NIAID experiments “have given us some modest scientific knowledge and done almost nothing to improve our preparedness for pandemic, and yet risked creating an accidental pandemic.”

Dr. Fauci’s History in Spending Billions of Government Funds on Vaccine Research with Little to Show for it

Across the country, a debate is raging about the nation’s medical response and how best to apportion available resources. Many argue, quite reasonably, for the importance of identifying safe, effective and affordable therapies that can provide immediate help to those who are sick. On March 22, The New York Times reported that there are at least 69 existing drugs or compounds that might be effective in treating the coronavirus. In China, researchers are studying intravenous vitamin C as a potential nontoxic treatment, while a paper published by French researchers on March 20 described promising COVID-19 results from the off-label use of hydroxychloroquine (an antimalarial) and azithromycin (an antibiotic). The head of the French team, Didier Raoult, MD, PhD, is one of the world’s top infectious disease and virology experts, with roughly 2,000 peer-reviewed publications and multiple awards to his name. Raoult and coauthors point out that a major advantage of “repositioning” older drugs for this coronavirus is that their safety profile, side effects, dosing and drug interactions are already well documented. However, Ian Lipkin, MD, of Columbia University recently told MSNBC, with a grin, that investments tend to go toward treatments that are “sexy and new and patentable” rather than to “tried-and-true, classical sort of methods repurposing drugs and strategies that have already been shown to work.” For biopharma companies that are poised to profit from COVID-19-related misfortune, older drugs that have outlived their patent terms are not terribly helpful for the bottom line. Could this be why leading White House coronavirus advisor Anthony Fauci, MD, long-time head of the National Institute of Allergy and Infectious Diseases (NIAID), recently pooh-poohed the published chloroquine evidence as merely “anecdotal”? Fauci is a stalwart enthusiast of “patentable” vaccines, skilled in attracting massive government funding for vaccines that either never materialize or are spectacularly ineffective or unsafe.